You are viewing the site in preview mode
Skip to main content
|
Treatment
|
T1 (%)
|
T2 (%)
|
T3 (%)
|
T4 (%)
|
|---|
|
C
|
92.33 ± 1.20
|
10.33 ± 0.89
|
0
|
0
|
|
CAP
|
94.32 ± 1.02
|
5.66 ± 1.12
|
0
|
0
|
|
10c
|
49.67 ± 0.88*
|
38.32 ± 1.43*
|
12.01 ± 0.57*
|
0
|
|
(inv)10c
|
92.65 ± 0.86
|
7.36 ± 0.78
|
0
|
0
|
|
11e
|
91.67 ± 1.48
|
8.39 ± 0.90
|
0
|
0
|
|
AP
|
37.69 ± 2.35*
|
55.63 ± 3.06*
|
5.00 ± 0.53*
|
1.62 ± 0.23*
|
- The data are presented as the mean ± SEM. Types of degeneration tubular in each treatment [CAP, 10c, inv(10c), 11e and AP] were compared to the control (C), and significant differences as assessed through one-way ANOVA followed by the Tukey test as a post hoc test (* p < 0.05). Normal tubules (T1); hypospermatogenic tubules (T2); arrested maturation tubules (T3); tubules containing spermatogonia and Sertoli cells or Sertoli-cell-only tubules (T4). C, control; CAP, captopril; (inv)10c, containing the inverted BPP-10c sequence; 10c, BPP-10c; 11e, BPP-11e; AP, BPP-AP
